Healthcare Triangle, Inc. (HCTI) intrinsic value & 10-year financials
Healthcare Triangle, Inc. (HCTI) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 7 fiscal years revenue shrank 15.0% a year to $13.9M, with an average return on invested capital of -700.4%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.40
- Market cap
- $24.6K
- Revenue (FY2025)
- $13.9M
- Revenue growth (7-yr CAGR)
- -15.0%
- ROIC (10-yr avg)
- -700.4%
- Free cash flow (FY2025)
- -$16.5M
HCTI 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $13.9M | -$9.5M | -$152.30 | -$16.5M | -70.5% | -179.3% |
| FY2024 | $11.7M | -$6.0M | -$1.13 | — | -40.6% | -3816.1% |
| FY2023 | $33.2M | -$12.3M | -$2.92 | -$1.6M | -34.2% | -139.4% |
| FY2022 | $45.9M | -$9.6M | -$2.63 | -$2.6M | -22.7% | -69.2% |
| FY2021 | $35.3M | -$6.0M | -$0.20 | — | -15.2% | -32.3% |
| FY2020 | $31.3M | $2.4M | $0.08 | — | 3.8% | 33.7% |
| FY2019 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Healthcare Triangle, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Healthcare Triangle, Inc. has historically struggled to out-earn its cost of capital, averaging just -41.2% ROIC.
Healthcare Triangle, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Healthcare Triangle, Inc. is modeled at -15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-1.56 per share.